SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 102 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 58 | +132.0% | 0.00% | – |
| Q1 2022 | $1,000 | -99.8% | 25 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $458,000 | -95.7% | 18,455 | -94.3% | 0.00% | -95.0% |
| Q3 2021 | $10,732,000 | +14.3% | 325,000 | 0.0% | 0.02% | +11.1% |
| Q2 2021 | $9,393,000 | -45.0% | 325,000 | -3.5% | 0.02% | -45.5% |
| Q1 2021 | $17,064,000 | +56.2% | 336,823 | +49.6% | 0.03% | +50.0% |
| Q4 2020 | $10,923,000 | +310.8% | 225,089 | +49.8% | 0.02% | +266.7% |
| Q3 2020 | $2,659,000 | +5.4% | 150,290 | +8.5% | 0.01% | 0.0% |
| Q2 2020 | $2,522,000 | +83966.7% | 138,522 | +66178.5% | 0.01% | – |
| Q1 2020 | $3,000 | +200.0% | 209 | +3383.3% | 0.00% | – |
| Q4 2019 | $1,000 | -94.7% | 6 | -99.7% | 0.00% | – |
| Q3 2019 | $19,000 | -36.7% | 2,073 | +10.4% | 0.00% | – |
| Q2 2019 | $30,000 | -55.2% | 1,877 | -47.5% | 0.00% | – |
| Q1 2019 | $67,000 | +3.1% | 3,577 | +26.5% | 0.00% | – |
| Q4 2018 | $65,000 | – | 2,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |